Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Ballinger Insider Profile
4 Followers
Kevin Ballinger, EVP & Pres, Interven Cardio at Boston Scientific, holds 17.81K shares in Silk Road Medical (Ticker: SILK), holds 1.73K shares in Shockwave Medical (Ticker: SWAV), holds 80.08K shares in Boston Scientific (Ticker: BSX). Most recently, Kevin Ballinger Bought ― shares of Silk Road Medical on Mar 07, 2024 for an estimated value of 198.78K.
Kevin Ballinger Boston Scientific (BSX)EVP & Pres, Interven Cardio
Boston Scientific (BSX)
EVP & Pres, Interven Cardio
Ranked #62,131 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-9.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Ballinger holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Ballinger
Kevin Ballinger's Trading History
Boston Scientific
Mar 05, 2020
EVP & Pres, Interven Cardio
Uninformative Sell
124.44K
$5.76M
Silk Road Medical
Mar 07, 2024
Director
Informative Buy
198.78K
$346.17K
Shockwave Medical
Jun 15, 2023
Director
Uninformative Buy
―
$572.22K
List of latest transactions for each holding click on a transaction to see Kevin Ballinger's performance on stock
You May Also Like
Kevin Ballinger insider profile FAQ
What is the percentage of profitable transactions made by Kevin Ballinger?
The percentage of profitable transactions made by Kevin Ballinger is 33%.
What is the average return per transaction made by Kevin Ballinger?
The average return per transaction made by Kevin Ballinger is -9.90%.
What stocks does Kevin Ballinger hold?
Kevin Ballinger holds: BSX, SILK, SWAV stocks.
What was Kevin Ballinger’s latest transaction?
Kevin Ballinger latest transaction was an Informative Buy of $198.78K.
What was Kevin Ballinger's most profitable transaction?
Kevin Ballinger’s most profitable transaction was an Informative Buy of SILK stock on March 7, 2024. The return on the trade was 11.30%.
What is Kevin Ballinger's role in Boston Scientific?
Kevin Ballinger's role in Boston Scientific is EVP & Pres, Interven Cardio.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.